UC San Diego Maps Gene Control to Fight Heart Failure

Scientists at UC San Diego have built the most detailed map ever of what goes wrong inside failing hearts, and it could change how we treat the world's leading cause of death.

The research team analyzed over 750,000 individual heart cells from 36 people to understand how gene control systems break down during heart failure. Published in Science this month, the study reveals more than 10,000 genes that behave differently in failing hearts and over 50,000 DNA regions where gene control switches get flipped.

"Right now, one of the biggest limitations in cardiology is not the lack of tools, but the lack of targets," said Dr. Neil Chi, who led the study at UC San Diego School of Medicine. "This kind of data changes that."

Heart failure affects millions worldwide, yet doctors have only a handful of proven treatments. The problem isn't a lack of medical technology. It's that researchers haven't known exactly what to target with new drugs.

Most genetic studies point to DNA regions that don't make proteins but instead control when genes turn on or off. That's made it incredibly hard to figure out which genes to target and how.

The new atlas solves this puzzle by tracking not just which genes are active, but how they're controlled in 12 different types of heart cells. The team discovered that failing hearts have more scar tissue cells and fewer cells that make the heart beat. They also found the exact pathways cells take as they shift from healthy to diseased.

Why This Inspires

This research represents hope for the 26 million people living with heart failure who have few treatment options. By mapping exactly how genetic risk shows up in specific heart cells, scientists now have a clear roadmap for developing targeted therapies.

The study identified particular cell states where disease is "actively unfolding." If doctors can target these transition points, they might stop heart failure before it progresses. It's like having a detailed instruction manual for a broken engine instead of just guessing which part to fix.

Beyond heart disease, the research offers a new way to understand how genes contribute to illness. Instead of just listing genetic changes, scientists can now see exactly which cells are affected and which genes are controlled by those changes.

The team is already using this atlas to identify specific molecules that could become new drugs. After decades of limited options, heart failure patients may soon have access to treatments designed for their specific cellular problems.

This breakthrough shows what's possible when technology catches up with ambition.